Tags

Type your tag names separated by a space and hit enter

Population-wide benefits of routine vaccination of children against influenza.
Vaccine. 2005 Jan 26; 23(10):1284-93.V

Abstract

Using a stochastic simulation model of influenza transmission, clinical illness, and economic costs, we estimated the population-wide benefits of routinely vaccinating US children (ages 6 months to 18 years) against influenza. Disease burden was projected to decline as a result of both reduced susceptibility to infection among vaccinees and reductions in disease transmission to others in the community. Vaccination of 20% of children would reduce the total number of influenza cases in the US by 46%; 80% coverage would reduce the total number of cases by 91%. Similar reductions were estimated to occur in influenza-related mortality and economic costs.

Authors+Show Affiliations

Policy Analysis Inc., Four Davis Court, Brookline, MA 02445, USA.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

15652671

Citation

Weycker, Derek, et al. "Population-wide Benefits of Routine Vaccination of Children Against Influenza." Vaccine, vol. 23, no. 10, 2005, pp. 1284-93.
Weycker D, Edelsberg J, Halloran ME, et al. Population-wide benefits of routine vaccination of children against influenza. Vaccine. 2005;23(10):1284-93.
Weycker, D., Edelsberg, J., Halloran, M. E., Longini, I. M., Nizam, A., Ciuryla, V., & Oster, G. (2005). Population-wide benefits of routine vaccination of children against influenza. Vaccine, 23(10), 1284-93.
Weycker D, et al. Population-wide Benefits of Routine Vaccination of Children Against Influenza. Vaccine. 2005 Jan 26;23(10):1284-93. PubMed PMID: 15652671.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Population-wide benefits of routine vaccination of children against influenza. AU - Weycker,Derek, AU - Edelsberg,John, AU - Halloran,M Elizabeth, AU - Longini,Ira M,Jr AU - Nizam,Azhar, AU - Ciuryla,Vincent, AU - Oster,Gerry, PY - 2004/01/26/received PY - 2004/06/23/revised PY - 2004/08/16/accepted PY - 2005/1/18/pubmed PY - 2005/4/19/medline PY - 2005/1/18/entrez SP - 1284 EP - 93 JF - Vaccine JO - Vaccine VL - 23 IS - 10 N2 - Using a stochastic simulation model of influenza transmission, clinical illness, and economic costs, we estimated the population-wide benefits of routinely vaccinating US children (ages 6 months to 18 years) against influenza. Disease burden was projected to decline as a result of both reduced susceptibility to infection among vaccinees and reductions in disease transmission to others in the community. Vaccination of 20% of children would reduce the total number of influenza cases in the US by 46%; 80% coverage would reduce the total number of cases by 91%. Similar reductions were estimated to occur in influenza-related mortality and economic costs. SN - 0264-410X UR - https://www.unboundmedicine.com/medline/citation/15652671/Population_wide_benefits_of_routine_vaccination_of_children_against_influenza_ DB - PRIME DP - Unbound Medicine ER -